The Claim

The incidence of cancer detection per round of whole-body MRI screening in asymptomatic TP53 carriers is 2% (95% CI: 0.01–0.04), including both baseline and follow-up assessments.

Source: Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports

42score

Challenges

0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative

1 study reviewed

In plain English

When people with a specific gene mutation (TP53) who feel fine get a full-body MRI scan, about 2 out of every 100 of them are found to have cancer during the scan — whether it’s their first scan or a later one.

See the scientific wording

The incidence of cancer detection per round of whole-body MRI screening in asymptomatic TP53 carriers is 2% (95% CI: 0.01–0.04), including both baseline and follow-up assessments.

What the research says

1 study

Study: Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis
The study checked if whole-body MRI scans find cancer in people with a high cancer risk gene (TP53), and it found that about 2 out of every 100 scans found cancer — just like the claim said.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.